Product sourcing reference

SS-31

SS-31, also known as elamipretide, is a mitochondria-targeted tetrapeptide. Distinguish the investigational research compound from any regulated finished product.

Reference variants

Add SS-31 to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

10mgVial · confirm physical formCAS 736992-21-5

$18.69/vial$14.95/vial at 1,000+ vials of this item

Quantity of SS-31 10mg in vials vials, packs of 10

Review your order request · Compare the full catalog

Confirm the exact substance

Elamipretide has been evaluated in clinical programmes for specific mitochondrial conditions. That clinical work concerns a defined product and does not authorize general use of research material.

What the review will ask

Ask for the salt form and counter-ion, since SS-31 is commonly supplied as a hydrochloride or acetate, and record the intended use for the eligibility review.

State the facility type, destination state and intended transaction. Do not send patient information.
Expect product- and lot-specific documentation to be requested before any material is accepted.
A listed price is a reference estimate. Availability, labeling, shipping and terms are confirmed in writing only after review.

Purchasing questions

Is SS-31 the same as elamipretide?

SS-31 is the research name for the same peptide sequence. Whether a given material matches a regulated product depends on its specification, not its name.

Separate an ingredient reference from a regulated product

SS-31 and elamipretide naming alone cannot establish that a reference vial matches a finished medicine. Approval information must be checked against the exact manufacturer, formulation and labeled use.

Documentation to request

Request the salt/counter-ion, specification and product regulatory record. Do not transfer a finished product's status to unspecified research material.

Regulatory context: FDA: compounding, approval and quality standards. Source reviewed 2026-10-16. This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Longevity clinic documentation questions. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. This reference is not medical or legal advice and does not establish a lawful supply route.

Discuss sourcing requirements